These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 10425272)

  • 1. Preventive and therapeutic effect of tumor derived heat shock protein, gp96, in an experimental prostate cancer model.
    Yedavelli SP; Guo L; Daou ME; Srivastava PK; Mittelman A; Tiwari RK
    Int J Mol Med; 1999 Sep; 4(3):243-8. PubMed ID: 10425272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in glycosylation patterns of heat shock protein, gp96: implications for prostate cancer prevention.
    Suriano R; Ghosh SK; Ashok BT; Mittelman A; Chen Y; Banerjee A; Tiwari RK
    Cancer Res; 2005 Jul; 65(14):6466-75. PubMed ID: 16024652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heat shock protein gp96 and cancer immunotherapy.
    Peibin Y; Shude Y; Changzhi H
    Chin Med Sci J; 2002 Dec; 17(4):251-6. PubMed ID: 12901515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active-specific immunotherapy of human cancers with the heat shock protein Gp96-revisited.
    Randazzo M; Terness P; Opelz G; Kleist C
    Int J Cancer; 2012 May; 130(10):2219-31. PubMed ID: 22052568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Granulocyte-macrophage colony-stimulating factor gene-transduced tumor cells combined with tumor-derived gp96 inhibit tumor growth in mice.
    Kojima T; Yamazaki K; Tamura Y; Ogura S; Tani K; Konishi J; Shinagawa N; Kinoshita I; Hizawa N; Yamaguchi E; Dosaka-Akita H; Nishimura M
    Hum Gene Ther; 2003 May; 14(8):715-28. PubMed ID: 12804136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of efficacy of immunotherapy with tumor-derived heat shock protein gp96.
    Kovalchin JT; Murthy AS; Horattas MC; Guyton DP; Chandawarkar RY
    Cancer Immun; 2001 Apr; 1():7. PubMed ID: 12747768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination with autologous tumor-derived heat-shock protein gp96 after liver resection for metastatic colorectal cancer.
    Mazzaferro V; Coppa J; Carrabba MG; Rivoltini L; Schiavo M; Regalia E; Mariani L; Camerini T; Marchianò A; Andreola S; Camerini R; Corsi M; Lewis JJ; Srivastava PK; Parmiani G
    Clin Cancer Res; 2003 Aug; 9(9):3235-45. PubMed ID: 12960108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biophysical analysis of the endoplasmic reticulum-resident chaperone/heat shock protein gp96/GRP94 and its complex with peptide antigen.
    Linderoth NA; Simon MN; Rodionova NA; Cadene M; Laws WR; Chait BT; Sastry S
    Biochemistry; 2001 Feb; 40(5):1483-95. PubMed ID: 11170476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of heat shock protein-based vaccines by intracellular loading of gp96 with antigenic peptides.
    Heikema A; Agsteribbe E; Wilschut J; Huckriede A
    Immunol Lett; 1997 Jun; 57(1-3):69-74. PubMed ID: 9232428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phylogenetic conservation of the molecular and immunological properties of the chaperones gp96 and hsp70.
    Robert J; Ménoret A; Basu S; Cohen N; Srivastava PR
    Eur J Immunol; 2001 Jan; 31(1):186-95. PubMed ID: 11265634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy using heat-shock protein preparations of leukemia cells after syngeneic bone marrow transplantation in mice.
    Sato K; Torimoto Y; Tamura Y; Shindo M; Shinzaki H; Hirai K; Kohgo Y
    Blood; 2001 Sep; 98(6):1852-7. PubMed ID: 11535521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-priming of minor histocompatibility antigen-specific cytotoxic T cells upon immunization with the heat shock protein gp96.
    Arnold D; Faath S; Rammensee H; Schild H
    J Exp Med; 1995 Sep; 182(3):885-9. PubMed ID: 7650492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization of cancer patients with autologous cancer-derived heat shock protein gp96 preparations: a pilot study.
    Janetzki S; Palla D; Rosenhauer V; Lochs H; Lewis JJ; Srivastava PK
    Int J Cancer; 2000 Oct; 88(2):232-8. PubMed ID: 11004674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Large-scale in vitro preparation of new gp96 tumor vaccine and analysis of its induction of specific anti-tumor immunoresponses].
    Yan X; Li C; Zhang X; Ju Y; Zhao B; Meng S
    Sheng Wu Gong Cheng Xue Bao; 2011 Nov; 27(11):1598-605. PubMed ID: 22393714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myeloma cell line-derived, pooled heat shock proteins as a universal vaccine for immunotherapy of multiple myeloma.
    Qian J; Hong S; Wang S; Zhang L; Sun L; Wang M; Yang J; Kwak LW; Hou J; Yi Q
    Blood; 2009 Oct; 114(18):3880-9. PubMed ID: 19654406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of peptides with heat shock protein gp96 occurs in vivo and not after cell lysis.
    Ménoret A; Peng P; Srivastava PK
    Biochem Biophys Res Commun; 1999 Sep; 262(3):813-8. PubMed ID: 10471407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The contribution of NT-gp96 as an adjuvant for increasing HPV16 E7-specific immunity in C57BL /6 mouse model.
    Mohit E; Bolhassani A; Zahedifard F; Taslimi Y; Rafati S
    Scand J Immunol; 2012 Jan; 75(1):27-37. PubMed ID: 21916914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastric cancer-derived heat shock protein-gp96 peptide complex enhances dendritic cell activation.
    Lu WW; Zhang H; Li YM; Ji F
    World J Gastroenterol; 2017 Jun; 23(24):4390-4398. PubMed ID: 28706421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heat shock protein-peptide complexes for use in vaccines.
    Heike M; Noll B; Meyer zum Büschenfelde KH
    J Leukoc Biol; 1996 Aug; 60(2):153-8. PubMed ID: 8773575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heat shock protein-peptide complexes, reconstituted in vitro, elicit peptide-specific cytotoxic T lymphocyte response and tumor immunity.
    Blachere NE; Li Z; Chandawarkar RY; Suto R; Jaikaria NS; Basu S; Udono H; Srivastava PK
    J Exp Med; 1997 Oct; 186(8):1315-22. PubMed ID: 9334371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.